~~<i id='50CCF86C82'><strike id='50CCF86C82'><tt id='50CCF86C82'><pre id='50CCF86C82'></pre></tt></strike></i>~~

Home» explore» focus

focus

author：knowledge 2025-10-06 18:58:33 Page View：4137

Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks.

“Oh, crap,” Secrist said to herself.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Google's generative AI to analyze medical images — and talk to docs
Next article： George Santos makes 1st court appearance after pleading not guilty to 13 counts

leisure time

Supreme Court strikes down use of affirmative action

ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

Failure, not just success, should guide future doctors

AdobeMatchDay,whichrolledaroundthisyearonMarch15,isarguablyoneofthemostimportantdaysinadoctor’slife.

What does generative AI mean for health care? We asked experts

MikeReddyforSTATHealthcarecompaniesareracingtoincorporategenerativeAItoolsintotheirproductpipelinesa

Trump used to be more articulate. What could explain the change?

DomSmith/STATItwasthekindofutterancethatmakesprofessionaltranscribersquestiontheircareerchoice:“…the